Drug intelligence / Profile preview

JenaProst

Development stage: Unknown
Lead developer: Jena Herbals
Administration: Oral

Overview

JenaProst is an herbal supplement developed by Jena Herbals Limited, a Ugandan company founded by Professor Patrick Ogwang. It is approved by the Uganda National Drug Authority (NDA) for the management of symptoms associated with benign prostatic hyperplasia (BPH) and for general prostate health. The product is marketed as a finished commercial herbal remedy rather than an investigational pharmaceutical drug. It is part of a broader portfolio of botanical products from Jena Herbals, which gained significant attention for the development of Covidex.

Brand names: JenaProst
Other names: Jena Prost

Targets

SRD5A (Steroid 5-alpha-reductase)

Beyond the preview

Go deeper on JenaProst.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JenaProst.

Explore the full profile